Patient Safety/ Medical Error

Contributing journals to this collection:
JAMA & Archives Journals

Citations 81-90 of 525 total displayed.

Past content

Letters
Hospital Mortality and Leapfrog Hospital Survey Results

Peter B. Angood; Helen Burstin
JAMA 2009; 302: 625-626. [Extract] [Full text] [PDF]  

Letters
Hospital Mortality and Leapfrog Hospital Survey Results—Reply

Leslie P. Kernisan; R. Adams Dudley
JAMA 2009; 302: 626. [Extract] [Full text] [PDF]  

Clinical Crossroads
A 62-Year-Old Woman With Skin Cancer Who Experienced Wrong-Site Surgery: Review of Medical Error

Thomas H. Gallagher
JAMA 2009; 302: 669-677. [Abstract] [Full text] [PDF] [ Author in the Room® Teleconference ]  

Editorials
Do Hospitalists Improve Quality?

Robert M. Centor; Benjamin B. Taylor
Arch Intern Med 2009; 169: 1351-1352. [Extract] [Full text] [PDF]  

Original Investigations
Use of Simulation-Based Education to Reduce Catheter-Related Bloodstream Infections

Jeffrey H. Barsuk; Elaine R. Cohen; Joe Feinglass; William C. McGaghie; Diane B. Wayne
Arch Intern Med 2009; 169: 1420-1423. [Abstract] [Full text] [PDF]  

Original Articles
Use of Board Certification and Recertification in Hospital Privileging: Policies for General Surgeons, Surgical Specialists, and Nonsurgical Subspecialists

Gary L. Freed; Kelly M. Dunham; Dianne Singer
Arch Surg 2009; 144: 746-752. [Abstract] [Full text] [PDF]  

Invited Critique
Use of Board Certification and Recertification in Hospital Privileging—Invited Critique

L. D. Britt
Arch Surg 2009; 144: 752. [Extract] [Full text] [PDF]  

Corrections
Errors in Tables and Figure in: Outcomes Following Thyroid and Parathyroid Surgery in Pregnant Women

Arch Surg 2009; 144: 779. [Full text] [PDF]  

Original Investigations
Agreement Between Drugs-to-Avoid Criteria and Expert Assessments of Problematic Prescribing

Michael A. Steinman; Gary E. Rosenthal; C. Seth Landefeld; Daniel Bertenthal; Peter J. Kaboli
Arch Intern Med 2009; 169: 1326-1332. [Abstract] [Full text] [PDF] [ eTable ]  

Invited Commentary
Agreement Between Drugs-to-Avoid Criteria and Expert Assessments of Problematic Prescribing—Invited Commentary

Daniel S. Budnitz
Arch Intern Med 2009; 169: 1332-1334. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53